Stage IVB Lung Cancer AJCC v8 Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0111251 (Stage IVB Lung Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03590054A Phase 1b Dose Escalation/Expansion Study of Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesTreatment